September 26, 2011
Ono Pharmaceutical and Astellas launched once-every-four-weeks versions of the oral treatment for osteoporosis Recalbon Tablet 50 mg and Bonoteo Tablet 50 mg (minodronic acid), respectively, on September 16. The NHI price for both products was set at ¥3,433.40 per tablet...read more